Ameritas Investment Partners, Inc. Tricida, Inc. Transaction History

Ameritas Investment Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$7.31 - $11.85 $18,253 - $29,589	2,497 New	2,497 $24,000
Q2 2021 Aug 06, 2021	SELL	$3.95 - $5.41 $9,867 - $13,514	-2,498 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$21.21 - $31.55 $13,383 - $19,908	631 Added 33.8%	2,498 $69,000
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $12,183 - $15,428	391 Added 26.49%	1,867 $74,000
Q1 2019 May 15, 2019	BUY	$19.96 - $38.62 $10,259 - $19,850	514 Added 53.43%	1,476 $57,000
Q3 2018 Nov 13, 2018	BUY	$22.5 - $39.35 $21,645 - $37,854	962 New	962 $29,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.